Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(14)
BIOLOGICAL(2)
DEVICE(2)
PROCEDURE(1)
Cyclosporin
2 trials
phase_2
national-heart-lung-and-blood-institute-nhlbi
AMD3100 (Mozobil plerixafor)
2 trials
phase_2
national-heart-lung-and-blood-institute-nhlbi
G-CSF
2 trials
phase_2
national-heart-lung-and-blood-institute-nhlbi
methotrexate
2 trials
phase_2
national-heart-lung-and-blood-institute-nhlbi
Peripheral Blood Stem Cells
1 trial
phase_2
national-heart-lung-and-blood-institute-nhlbi
Donor derived G-CSF mobilized PBC
1 trial
phase_2
national-heart-lung-and-blood-institute-nhlbi
Bortezomib
1 trial
phase_1
national-heart-lung-and-blood-institute-nhlbi
cell infusion
1 trial
phase_1
national-heart-lung-and-blood-institute-nhlbi

+9 more interventions

17 unique interventions6 categories

Analytics

Trial Phases

Phase 15
Phase 28

Trial Status

Completed8
Recruiting4
Terminated1
Other2

Role Distribution

Principal Investigator15
PI Rate100%

Activity Timeline

Clinical Trials (15)

NCT03520647Phase 2Recruiting
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)Severe Aplastic Anemia (SAA)
PrincipalinvestigatorStart date: 2019-02-19
NCT03354390Phase 1Active Not Recruiting
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Kidney Cancer
PrincipalinvestigatorStart date: 2018-07-20
NCT03511794Completed
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
Hepatitis B
PrincipalinvestigatorStart date: 2018-04-13
NCT03173937Phase 1/2Recruiting
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Hypo-Plastic MDSMyelodysplastic Syndrome (MDS)Severe Aplastic Anemia
PrincipalinvestigatorStart date: 2017-06-13
NCT01174108Phase 2Recruiting
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
MDS (Myelodysplastic Syndrome)Severe Aplastic Anemia
PrincipalinvestigatorStart date: 2010-12-10
NCT01092195Phase 1Completed
Gardasil Vaccination in Post Stem Cell Transplant Patients
Gardasil VaccineImmunogenicityStem Cell Transplant
PrincipalinvestigatorStart date: 2010-06-02
NCT00720785Phase 1Completed
Natural Killer Cells and Bortezomib to Treat Cancer
Carcinoma, Non-Small -Cell LungChronic Myeloid Leukemia (CML)Colon/Rectal Ca+2 more
PrincipalinvestigatorStart date: 2008-08-01
NCT00604201Phase 2Completed
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)Severe Aplastic Anemia (SAA)
PrincipalinvestigatorStart date: 2008-05-21
NCT00322127Phase 1Completed
An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers
Healthy Volunteers
PrincipalinvestigatorStart date: 2006-06-14
NCT00106925Recruiting
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Graft RejectionGraft vs Host DiseaseGraft-versus-leukemia
PrincipalinvestigatorStart date: 2005-04-22

Showing 10 of 15 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsGraft vs Host Disease+3 more
Similarity Score6%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+2 more
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+2 more
Similarity Score5%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma+2 more
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of KidneyHematologic Neoplasms+1 more
Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

NeoplasmsCarcinoma, Non-Small-Cell LungNeoplasm Metastasis
Similarity Score3%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

HealthyHealthy VolunteersHematologic Neoplasms
Similarity Score3%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaCarcinoma, Non-Small-Cell Lung
Similarity Score2%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungCancer of Kidney
Similarity Score2%

Britt Burton-Freeman, ph.D

Illinois Institute of Technology

Related
23 trials

Shared therapeutic areas:

HealthyHealthy Volunteers
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (15)

Showing 15 of 15 trials

NCT03520647Phase 2PrincipalInvestigator

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Hypo-Plastic Myelodysplastic Syndrome (MDS)Paroxysmal Nocturnal Hemoglobinuria (PNH)Severe Aplastic Anemia (SAA)
Recruiting
NCT03354390Phase 1PrincipalInvestigator

HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Kidney Cancer
Active Not Recruiting
NCT03511794PrincipalInvestigator

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

Hepatitis B
Completed
NCT03173937Phase 1/2PrincipalInvestigator

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Hypo-Plastic MDSMyelodysplastic Syndrome (MDS)Severe Aplastic Anemia
Recruiting
NCT01174108Phase 2PrincipalInvestigator

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome)Severe Aplastic Anemia
Recruiting
NCT01092195Phase 1PrincipalInvestigator

Gardasil Vaccination in Post Stem Cell Transplant Patients

Gardasil VaccineImmunogenicityStem Cell Transplant
Completed
NCT00720785Phase 1PrincipalInvestigator

Natural Killer Cells and Bortezomib to Treat Cancer

Carcinoma, Non-Small -Cell LungChronic Myeloid Leukemia (CML)Colon/Rectal Ca+2 more
Completed
NCT00604201Phase 2PrincipalInvestigator

Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)Severe Aplastic Anemia (SAA)
Completed
NCT00322127Phase 1PrincipalInvestigator

An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

Healthy Volunteers
Completed
NCT00106925PrincipalInvestigator

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Graft RejectionGraft vs Host DiseaseGraft-versus-leukemia
Recruiting
NCT00082329Phase 2PrincipalInvestigator

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Healthy
Completed
NCT00071045PrincipalInvestigator

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

Healthy VolunteersHematologic NeoplasmsNeoplasms
Enrolling By Invitation
NCT00003838Phase 2PrincipalInvestigator

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
Completed
NCT00001880Phase 2PrincipalInvestigator

Stem Cell Transplantation for Metastatic Solid Tumors

Neoplasm Metastasis
Terminated
NCT00075335Phase 2PrincipalInvestigator

AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation

Healthy
Completed

All 15 trials loaded